Skip to main content

Peer Review reports

From: Janus kinase inhibitors vs. abatacept about safety and efficacy for patients with rheumatoid arthritis-associated interstitial lung disease: a retrospective nested case-control study

Original Submission
3 May 2023 Submitted Original manuscript
19 May 2023 Author responded Author comments - Shiro Ohshima
Resubmission - Version 2
19 May 2023 Submitted Manuscript version 2
3 Jun 2023 Reviewed Reviewer Report
17 Jun 2023 Author responded Author comments - Shiro Ohshima
Resubmission - Version 3
17 Jun 2023 Submitted Manuscript version 3
5 Sep 2023 Reviewed Reviewer Report
15 Oct 2023 Reviewed Reviewer Report
10 Dec 2023 Author responded Author comments - Shiro Ohshima
Resubmission - Version 4
10 Dec 2023 Submitted Manuscript version 4
13 Dec 2023 Author responded Author comments - Shiro Ohshima
Resubmission - Version 5
13 Dec 2023 Submitted Manuscript version 5
24 Dec 2023 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
12 Jan 2024 Editorially accepted
26 Jan 2024 Article published 10.1186/s41927-024-00374-x

You can find further information about peer review here.

Back to article page